Results 31 to 40 of about 2,423,479 (187)

Cutaneous adverse reactions after COVID‐19 vaccines in a cohort of 2740 Italian subjects: An observational study

open access: yesDermatologic Therapy, 2021
An in‐depth characterization of the incidence, morphology, and onset of COVID‐19‐vaccines cutaneous adverse reactions is currently lacking. The existing literature on COVID‐19 vaccination‐related cutaneous adverse reactions largely focused on messenger ...
T. Grieco   +8 more
semanticscholar   +1 more source

Factors that influence cutaneous reactions following administration of thiopentone and atracurium [PDF]

open access: yesAnaesthesia, 1988
SummaryAtracurium was administered by a variety of techniques to determine whether these influence the onset or duration of muscular relaxation, and the frequency of cutaneous reactions, after a standard induction dose of thiopentone. One‐hundred‐and‐fifty patients were allocated randomly to receive the drug by one of five methods: into a fast‐flowing ...
J.E. Reid   +3 more
openaire   +4 more sources

Evaluation of Hydrogel Suppositories for Delivery of 5-Aminolevulinic Acid and Hematoporphyrin Monomethyl Ether to Rectal Tumors

open access: yesMolecules, 2016
We evaluated the potential utility of hydrogels for delivery of the photosensitizing agents 5-aminolevulinic acid (ALA) and hematoporphyrin monomethyl ether (HMME) to rectal tumors.
Xuying Ye   +4 more
doaj   +1 more source

Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review

open access: yesCase Reports in Rheumatology, 2017
We describe the case of a 48-year-old man with dermatomyositis (DM) who demonstrated rapidly progressive interstitial lung disease (RP-ILD) and refractory cutaneous involvement together with high levels of anti-melanoma differentiation-associated gene 5 ...
Yuka Ogawa   +4 more
semanticscholar   +1 more source

Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series *

open access: yesBritish Journal of Dermatology, 2021
Mogamulizumab is a humanized antibody against chemokine receptor type 4. It was recently approved by the US Food and Drug Administration for relapsed or refractory mycosis fungoides (MF) and Sézary syndrome (SS).
N. Trum   +9 more
semanticscholar   +1 more source

Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia

open access: yesIndian Journal of Medical and Paediatric Oncology, 2013
Zygomycetes are one of the less common causes of invasive fungal infections in patients with the hematological malignancies. We report two cases of acute lymphoblastic leukemia in the pediatric age group, complicated by disseminated cutaneous ...
Anshul Gupta   +3 more
doaj   +1 more source

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model

open access: yesPharmaceutics, 2022
In the last years, microneedles (MNs) have been considered a valuable, painless, and minimally invasive approach for controlled transdermal drug delivery (TDD).
Tânia M. T. Guimarães   +8 more
doaj   +1 more source

In situ film forming fibroin gel intended for cutaneous administration [PDF]

open access: yesInternational Journal of Pharmaceutics, 2016
The possible use of regenerated silk fibroin gels as in situ film forming formulations for cutaneous administration of drugs was studied. Ethanol was selected as volatile and skin tolerant solvent to favor the sol-gel transition of silk fibroin solutions. Glycerin was chosen to ameliorate the gel texture profile.
C.G.M. Gennari   +7 more
openaire   +4 more sources

On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations

open access: yesAntioxidants, 2021
Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids
R. Costa   +3 more
semanticscholar   +1 more source

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma

open access: yesFrontiers in Oncology, 2021
Cutaneous squamous cell carcinoma (CSCC) accounts for approximately 20% of all keratinocytic tumors. In most cases, the diagnosis and treatments are made on small, low-risk lesions.
A. Boutros   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy